 |
|
The Prognosis of Primary Tumors of the Iris Treated by Iridectomy
BENJAMIN RONES, M.D.;
LORENZ E. ZIMMERMAN, M.D.
AMA Arch Ophthalmol. 1958;60(2):193-205.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Over the years it has become increasingly evident that tumors of the iris should not be lumped with those of the ciliary body and choroid. They present entirely different problems in clinical diagnosis and surgical management, and there is mounting evidence to support the belief that biologically they may be different tumors. Progress in the study of these tumors has been slow, for they are not common, and a large volume of material with many years of follow-up is necessary for the accumulation of a series of cases from which lessons can be learned. Reese,1 for example, stated that at the Institute of Ophthalmology, in New York. 271 malignant melanomas of the uvea included only 23 that were primary in the iris. More recently, Duke and Dunn2 reviewed the primary tumors of the iris in the pathology laboratory of the Wilmer Institute and were able to report only
. . . [Full Text PDF of this Article]
Author Affiliations
Washington, D. C.
From the Registry of Ophthalmic Pathology, Armed Forces Institute of Pathology. Director, Ophthalmic Pathology Laboratory, Washington Hospital Center (Dr. Rones); Pathologist-Specialist, Veterans' Administration Central Laboratory for Pathologic Anatomy and Research, and Chief, Section on Ophthalmic Pathology, Armed Forces Institute of Pathology (Dr. Zimmerman).
Footnotes
Aided by Grant B1021, National Institute of Neurological Diseases and Blindness, U. S. Public Health Service.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
